Exicure Inc (XCUR)

Jun 18, 2025

Exicure (NASDAQ:XCUR) Stock Price Down 5.8% – Here’s Why - Defense World

Jun 18, 2025

Jun 13, 2025

What's Going On With Exicure Shares Monday? - MSN

Jun 13, 2025

Jun 10, 2025

Trading (XCUR) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 10, 2025

Jun 03, 2025

XCURExicure, Inc. Reports Full Year 2024 Financial Results - mx.advfn.com

Jun 03, 2025

May 29, 2025

Exicure faces Nasdaq non-compliance notice By Investing.com - Investing.com South Africa

May 29, 2025

May 29, 2025

(XCUR) Trading Report - news.stocktradersdaily.com

May 29, 2025

May 28, 2025

Exicure Receives Nasdaq Delinquency Notification - TipRanks

May 28, 2025

May 28, 2025

Exicure faces Nasdaq non-compliance notice - Investing.com Australia

May 28, 2025

May 28, 2025

Exicure (XCUR) Faces Nasdaq Non-Compliance Due to Delayed Report - GuruFocus

May 28, 2025

May 28, 2025

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q | XCUR Stock News - GuruFocus

May 28, 2025

May 28, 2025

Exicure Receives Noncompliance Notice From Nasdaq - marketscreener.com

May 28, 2025

May 28, 2025

Exicure (XCUR) Faces Nasdaq Non-Compliance Due to Delayed Report | XCUR Stock News - GuruFocus

May 28, 2025

May 28, 2025

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q - Business Wire

May 28, 2025

May 27, 2025

Exicure (NASDAQ:XCUR) Trading Down 4.5% – Here’s Why - Defense World

May 27, 2025

May 19, 2025

Exicure (XCUR) Is Paying a $5.6M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 19, 2025

May 15, 2025

Exicure Delays 10-Q Filing Amid Acquisition - TipRanks

May 15, 2025

May 08, 2025

(XCUR) Investment Analysis and Advice - news.stocktradersdaily.com

May 08, 2025

May 06, 2025

Exicure enters strategic convertible bond agreement By Investing.com - Investing.com Nigeria

May 06, 2025

May 06, 2025

Exicure Enters Convertible Bond Agreement with Subsidiary - TipRanks

May 06, 2025

May 06, 2025

Exicure enters strategic convertible bond agreement - Investing.com

May 06, 2025

May 06, 2025

Exicure concludes subject enrolment in trial of GPC-100 for multiple myeloma - Yahoo Finance

May 06, 2025

May 05, 2025

Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant | XCUR Stock News - GuruFocus

May 05, 2025

May 05, 2025

Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant - Business Wire

May 05, 2025

May 04, 2025

Geode Capital Management LLC Purchases Shares of 12,645 Exicure, Inc. (NASDAQ:XCUR) - Defense World

May 04, 2025

May 04, 2025

Exicure, Inc. (NASDAQ:XCUR) Sees Significant Drop in Short Interest - Defense World

May 04, 2025

May 02, 2025

Investors Can Still File Late Claims for Exicure $5.6M Settlement Payouts - TradingView

May 02, 2025

Apr 30, 2025

Why Exicure Inc. (XCUR) Soared on Monday - MSN

Apr 30, 2025

Apr 22, 2025

How To Trade (XCUR) - news.stocktradersdaily.com

Apr 22, 2025

Apr 21, 2025

10 Micro-, Small-Cap Companies Lead Monday’s Charge - Insider Monkey

Apr 21, 2025

Apr 19, 2025

Exicure, Inc. (NASDAQ:XCUR) Sees Large Drop in Short Interest - Defense World

Apr 19, 2025

Apr 15, 2025

Exicure Close to Finishing Patient Recruitment in Phase 2 Study of GPC-100 in Multiple Myeloma - MarketScreener

Apr 15, 2025

Apr 15, 2025

Exicure appoints new independent accounting firm By Investing.com - Investing.com India

Apr 15, 2025

Apr 14, 2025

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma - BioSpace

Apr 14, 2025

Apr 14, 2025

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study o - GuruFocus

Apr 14, 2025

Apr 14, 2025

Exicure appoints new independent accounting firm - Investing.com Australia

Apr 14, 2025

Apr 14, 2025

Breakthrough: New Multiple Myeloma Treatment Achieves Perfect Success Rate in Trial - Stock Titan

Apr 14, 2025

Apr 11, 2025

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML) - BioSpace

Apr 11, 2025

Apr 06, 2025

How to Take Advantage of moves in (XCUR) - news.stocktradersdaily.com

Apr 06, 2025

Apr 06, 2025

Eli Lilly and Company (NYSE:LLY) and Exicure (NASDAQ:XCUR) Head to Head Analysis - Defense World

Apr 06, 2025

Mar 30, 2025

Exicure, Inc. (NASDAQ:XCUR) Sees Significant Growth in Short Interest - The AM Reporter

Mar 30, 2025

Mar 29, 2025

Short Interest in Exicure, Inc. (NASDAQ:XCUR) Grows By 58.5% - Defense World

Mar 29, 2025

Mar 27, 2025

Wednesday’s Insider Moves: Top Buys and Sells in US Stocks - Investing.com India

Mar 27, 2025

Mar 27, 2025

Wednesday’s Insider Moves: Top Buys and Sells in US Stocks By Investing.com - Investing.com UK

Mar 27, 2025

Mar 26, 2025

Major Investment Alert: HiTron Systems Inc. Boosts Stake in Exicure! - TipRanks

Mar 26, 2025

Mar 26, 2025

HiTron Systems acquires $8.7 million in Exicure stock By Investing.com - Investing.com Canada

Mar 26, 2025

Mar 26, 2025

HiTron Systems acquires $8.7 million in Exicure stock - Investing.com

Mar 26, 2025

Mar 22, 2025

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Business Wire

Mar 22, 2025